Divi's Laboratories Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Divi's Laboratories Ltd. on BSE

Load latest

Divi's Laboratories Ltd.

23 Dec 2016

6279.50

1.05%

Company Update

Clarifies on News Item

BSE India

With reference to news appeared in CNBC TV 18 dated December 23, 2016 quoting "Emkay says on Vizag 483 observation:1. proper control not being exercised over computer system2. facility equipments not maintained to ensure purity quality strength3. documentation and records not maintained or inaccurate falsified "Divis Laboratories Ltd has submitted to BSE a copy of Clarification is enclosed.

pdf

Divi's Laboratories Ltd.

23 Dec 2016

6279.50

1.05%

Company Update

Clarification sought from Divis Laboratories Ltd

BSE India

The Exchange has sought clarification from Divis Laboratories Ltd on December 23, 2016 with reference to news appeared in CNBC TV 18 dated December 23, 2016 quoting "Emkay says on Vizag 483 observation:1. proper control not being exercised over computer system2. facility equipments not maintained to ensure purity quality strength3. documentation and records not maintained or inaccurate falsified "The reply is awaited.

Divi's Laboratories Ltd.

07 Dec 2016

6279.50

1.05%

Company Update

US-FDA Inspection of Unit -II at Visakhapatnam

BSE India

Divis Laboratories Ltd has informed BSE that the Company's Unit-II at Visakhapatnam, Andhra Pradesh has had an inspection by the US-FDA from November 29, 2016 to December 06, 2016. The Company have been issued a form 483 with 5 observations and these shall be responded within the time permitted.

pdf

Divi's Laboratories Ltd.

30 Nov 2016

6279.50

1.05%

Company Update

Updates

BSE India

Divis Laboratories Ltd has submitted to BSE a copy of notice sent to shareholders of the company in respect of transfer of equity shares of the company to Investor Education and Protection Fund (IEPF) Suspense Account, published in newspapers.

pdf

Divi's Laboratories Ltd.

12 Nov 2016

6279.50

1.05%

Result

Announces Q2 Results (Standalone), Limited Review Report (Standalone) & Results Press Release for the Quarter ended …

BSE India

Divis Laboratories Ltd has announced the Unaudited Standalone results for the quarter ended September 30, 2016 The Company has posted a net profit of Rs. 2238.50 million for the quarter ended September 30, 2016 as compared to Rs. 2969.00 million for the quarter ended September 30, 2015. Total Income has increased from Rs. 10016.90 million for the quarter ended September 30, 2015 to Rs. 10257.00 million for the quarter ended September 30, 2016.

pdf

Divi's Laboratories Ltd.

03 Nov 2016

6279.50

1.05%

Board Meeting

Q2 results on Nov 12, 2016

BSE India

Divis Laboratories Ltd has informed BSE that a meeting of Board of Directors of the Company is scheduled to be held on November 12, 2016, inter alia, to consider and approve the un-audited financial results for the quarter and half-year ended September 30, 2016 (Q2).Further, the Trading Window for dealing in securities of the Company shall remain closed for insiders of the Company from November 05, 2016 to November 14, 2016 (both days inclusive)...

pdf

Divi's Laboratories Ltd.

14 Oct 2016

6279.50

1.05%

Company Update

Shareholding for the Period Ended September 30, 2016

BSE India

Divis Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2016. For more details, kindly Click here

Divi's Laboratories Ltd.

11 Oct 2016

6279.50

1.05%

Company Update

Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended September …

BSE India

Divis Laboratories Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended September 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

pdf

Divi's Laboratories Ltd.

31 Aug 2016

6279.50

1.05%

Company Update

Clarification

BSE India

Divis Laboratories Ltd has informed BSE regarding "Clarification on news on import alert from US FDA".

pdf

Divi's Laboratories Ltd.

30 Aug 2016

6279.50

1.05%

AGM

Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

BSE India

Divis Laboratories Ltd has informed BSE regarding the details of Voting results at the 26th Annual General Meeting (AGM) of the Company held on August 29, 2016, under Regulation 44(3) of SEBI (LODR) Regulations, 2015 along with Scrutinizer's Report.

pdf

Is Divi's Laboratories Ltd. worth buying?

745 Votes:

Buy 78.12%

Sell 14.9%

Hold 6.98%

RESEARCH REPORTS

Hold SEE REPORTS >

pdf

Accumulate SEE REPORTS >

pdf